diacerein
EMA Approved
Description
Diacerein is an anthraquinone derivative with anti-inflammatory and chondroprotective properties. It has been investigated for use in skeletal dysplasias and cartilage disorders. The drug modulates interleukin-1 activity and has shown potential in managing symptoms of certain rare bone and cartilage conditions.
Indications & Therapeutic Use
osteoarthritis, skeletal dysplasias, cartilage disorders
Global Availability (6 countries)
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
diacerein
| Generic Name | diacerein |
| Brands | 1 brand available |
| Active Ingredient | diacerein |
| Drug Class | osteoarthritis |
| Manufacturer | TRB Chemedica |
| Dosage Forms | oral capsule, 50mg |
| Medical Code | M01AX21 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 14 days |
| Reg. Status | EMA Approved |
| Countries | 6 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations7 Validated Nodes